Koyfin Home > Directory > Health Care > Adma Biologics > Cash Flow from Operations

Adma Biologics Cash Flow from Operations Chart (ADMA)

Adma Biologics annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Adma Biologics Cash Flow from Operations for the quarter ending June 06, 2020 was $-21m a -11.02% increase of 2m year over year
  • Adma Biologics Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-89m a 15.56% decrease of -14m year over year
  • Adma Biologics Annual Cash Flow from Operations for 2019 was $-76m a 17.74% decrease of -14m from 2018
  • Adma Biologics Annual Cash Flow from Operations for 2018 was $-63m a 40.54% decrease of -25m from 2017
  • Adma Biologics Annual Cash Flow from Operations for 2017 was $-37m a 50.98% decrease of -19m from 2016
Other Cash Flow Metrics:
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Cash Flow from Operations Data

06/2020$-21m
03/2020$-25m
12/2019$-20m
09/2019$-24m
06/2019$-19m
03/2019$-14m
12/2018$-19m
09/2018$-13m
06/2018$-15m
03/2018$-16m

Annual ADMA Cash Flow from Operations Data

2019$-76m
2018$-63m
2017$-37m
2016$-18m
2015$-15m
2014$-15m
2013$-11m
2012$-7m
2011$-1m
2010$-5m